

Paradigm Shift: How New Tech is Shaping the Future of Clinical Trials
Apr 20, 2023
Suzanne Kincaid, Chief Operating Officer at Aperio Clinical Outcomes, discusses her journey from participating in a clinical trial to leading innovations in biotechnology research. She highlights how high-tech solutions improve workflow and early detection in trials. Kincaid emphasizes the role of decentralized trials in enhancing diversity and accessibility for participants. She shares insights on the importance of networking and mentorship in advancing careers within clinical research, showcasing the promising future of enhanced collaboration and efficiency in the field.
AI Snips
Chapters
Transcript
Episode notes
Unique Career Entry Story
- Suzanne Kincaid entered clinical research by answering a radio ad to participate in a trial and was offered part-time work filing documents.
- She progressed from a study coordinator to COO of Aperio Clinical Outcomes, focusing on early phase oncology trials.
Power of Centralized Monitoring
- Centralized monitoring and analytics allow early detection of quality and safety signals without on-site 100% source data verification.
- This enables early intervention and faster database closure with fewer surprises at trial end.
Technology Enhances Site Relationships
- Technology enables CRAs to focus on site relationships and patient care rather than paperwork.
- Flexible approaches reduce site burden and enhance support for both traditional and frontier sites.